Teva Launches First Generic Baraclude

Drug Industry Daily
A A
Israeli firm Teva has launched the first generic version of Bristol-Myers Squibb’s hepatitis B drug Baraclude in both its 0.5 mg and 1 mg tablet strengths.

To View This Article:

Login

Subscribe To Drug Industry Daily